AXA Résultats passés
Passé contrôle des critères 2/6
AXA a connu une croissance annuelle moyenne de ses bénéfices de 8%, tandis que le secteur Insurance a vu ses bénéfices augmenter de en hausse à 13.5% par an. Les revenus ont augmenté de en baisse à un taux moyen de 6.5% par an. Le rendement des capitaux propres de AXA est 14.4% et ses marges nettes sont de 7.7%.
Informations clés
8.00%
Taux de croissance des bénéfices
10.47%
Taux de croissance du BPA
| Insurance Croissance de l'industrie | 11.75% |
| Taux de croissance des recettes | -6.50% |
| Rendement des fonds propres | 14.36% |
| Marge nette | 7.68% |
| Prochaine mise à jour des résultats | 31 Jul 2026 |
Mises à jour récentes des performances passées
Recent updates
CS: Higher Fair Value And P/E Assumptions Will Support Measured Re Rating
AXA's analyst price target has edged higher by about €0.35, with analysts pointing to modestly revised assumptions around fair value, discount rate, profit margin and future P/E. This move is supported by recent research that includes both a €1 target increase and a €1 reduction from different banks, alongside a bullish initiation.CS: Technical And Fee-Based Shift Plus Buybacks Will Support Measured Re-Rating
AXA's fair value estimate edges higher to €46.12 from €46.07 as analysts refine assumptions around revenue growth, profit margins and future P/E, supported by a series of recent price target increases and bullish initiations on the stock. Analyst Commentary Recent Street research around AXA has been active, with several price target revisions and fresh initiations feeding into the updated fair value estimate.CS: Technical And Fee-Based Earnings Mix Will Support Re-Rating As Discount Persists
Analysts have nudged their average price target for AXA slightly higher to about €46.07. This reflects modest tweaks to assumptions around discount rates, profit margins and future P/E multiples, alongside recent Street research that includes both upward and downward target revisions clustered around the €46 to €50 range.CS: Technical And Fee-Based Earnings Shift Will Support Re-Rating As Discount Persists
AXA's analyst price targets have edged higher into a €46 to €50.70 range, as analysts point to improved profitability from technical insurance and fee-based earnings, along with what they view as an ongoing discount to European composite peers. Analyst Commentary Recent research points to a cluster of higher price targets for AXA, with analysts largely focused on the mix of technical insurance and fee-based earnings and how that feeds into profitability, earnings stability, and valuation relative to European peers.CS: Technical And Fee-Based Shift Will Support Re-Rating As Discount Persists
Analysts have nudged AXA's average price target higher to around €48 to €51, citing improved profitability from its focus on technical insurance and fee-based earnings and pointing out that the current valuation still sits at a discount to European composite peers. Analyst Commentary Recent Street research has tilted positive on AXA, with several banks lifting their price targets into a relatively tight band between €46 and about €51.CS: Technical And Fee-Based Shift Will Support Re-Rating Versus European Composite Peers
Our AXA fair value estimate has been adjusted from €45.27 to €46.05. This reflects higher analyst price targets in the €46 to €50.70 range and their focus on improved profitability, lower earnings volatility and a reduced P/E assumption.CS: Technical And Fee-Based Shift Will Support Higher Future Earnings Multiple
Analysts have nudged their price target for AXA slightly higher to about €45.27 from roughly €45.11, citing continued focus on technical insurance and fee-based earnings that they say is supporting improved profitability and a higher assumed future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts point to the shift towards technical insurance and fee-based earnings as a key support for more stable and higher quality profit streams, which they see as supportive of a stronger P/E multiple over time.CS: Slightly Lower Discount Rate Will Support Forward Earnings Appeal
The analyst fair value estimate for AXA has been adjusted slightly higher to €45.11 from €45.06, as analysts refine their assumptions around discount rates, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value Estimate adjusted slightly higher to €45.11 from €45.06.CS: Stable Assumptions And Slightly Higher Required Return Will Support Forward Earnings Appeal
Analysts have slightly raised their fair value estimate for AXA to €45.06 from €44.98, citing adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a marginally higher price target. Valuation Changes Fair value estimate is now set at €45.06, up slightly from €44.98, reflecting a very small adjustment in the model.CS: Stable Assumptions And Slightly Lower P/E Will Support Forward Earnings Appeal
Analysts have reduced their price target for AXA slightly to about €45, reflecting small adjustments to fair value estimates, discount rate assumptions and future P/E expectations, while keeping revenue growth and profit margin forecasts broadly unchanged. Valuation Changes Fair Value: Adjusted slightly from €45.07 to €44.98, indicating a very small reduction in the estimated fair value per share.CS: Lower Discount Rate Will Support Stronger Forward Earnings Appeal
Analysts have nudged their price target on AXA slightly higher to approximately €45.07 from about €45.04, citing a marginally lower discount rate and modest improvements in projected profit margins that together support a slightly richer valuation multiple. Valuation Changes Fair Value has risen slightly from approximately €45.04 to about €45.07, reflecting a marginal uplift in the intrinsic valuation estimate.CS: Modestly Higher Future Multiple Will Support Attractive Upside Potential
Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts. Valuation Changes Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.CS: Strong Profit Margins And Stable P/E Will Drive Future Gains
Analysts have slightly raised their price target for AXA, increasing it from €44.96 to €45.04. This change is based on modest adjustments to projected revenue growth, profit margins, and discount rates.CS: Rising Profit Margins And Multiples Will Drive Global Expansion
Analysts have slightly raised their price target for AXA from €44.58 to €44.96, citing incremental improvements in profit margin and expected future earnings multiples as key factors supporting the revision. Valuation Changes Fair Value has increased slightly from €44.58 to €44.96.These Analysts Think AXA SA's (EPA:CS) Sales Are Under Threat
ENXTPA:CS 1 Year Share Price vs Fair Value Explore AXA's Fair Values from the Community and select yours One thing we...Here's Why AXA (EPA:CS) Has Caught The Eye Of Investors
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Calculated Market Expansion And Innovative Products Drive Revenue Growth And Profitability
AXA's disciplined pricing and focus on operational excellence aim to enhance profitability in international markets.Ventilation des recettes et des dépenses
Comment AXA gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 94,691 | 7,274 | 0 | 0 |
| 30 Sep 25 | 93,951 | 7,203 | 0 | 0 |
| 30 Jun 25 | 93,211 | 7,132 | 0 | 0 |
| 31 Mar 25 | 92,233 | 7,131 | 0 | 0 |
| 31 Dec 24 | 91,255 | 7,130 | 0 | 0 |
| 30 Sep 24 | 86,183 | 7,431 | 0 | 0 |
| 30 Jun 24 | 88,570 | 6,640 | 0 | 0 |
| 31 Mar 24 | 87,144 | 6,654 | 0 | 0 |
| 31 Dec 23 | 85,717 | 6,667 | 0 | 0 |
| 30 Sep 23 | 86,192 | 5,932 | 0 | 0 |
| 30 Jun 23 | 85,233 | 4,859 | 0 | 0 |
| 31 Mar 23 | 86,013 | 4,869 | 0 | 0 |
| 31 Dec 22 | 86,793 | 4,879 | 0 | 0 |
| 30 Sep 22 | 95,691 | 5,920 | 2,685 | 0 |
| 30 Jun 22 | 104,588 | 6,961 | 5,369 | 0 |
| 31 Mar 22 | 113,380 | 7,031 | 7,878 | 0 |
| 31 Dec 21 | 122,171 | 7,100 | 10,386 | 0 |
| 30 Sep 21 | 121,905 | 6,324 | 10,423 | 0 |
| 30 Jun 21 | 121,639 | 5,548 | 10,460 | 0 |
| 31 Mar 21 | 116,993 | 4,268 | 10,588 | 0 |
| 31 Dec 20 | 112,347 | 2,987 | 10,716 | 0 |
| 30 Jun 20 | 110,232 | 2,769 | 10,454 | 0 |
| 31 Mar 20 | 121,671 | 3,198 | 10,588 | 0 |
| 31 Dec 19 | 133,109 | 3,627 | 10,722 | 0 |
| 30 Jun 19 | 124,037 | 1,822 | 11,531 | 0 |
| 31 Mar 19 | 115,231 | 2,064 | 11,254 | 0 |
| 31 Dec 18 | 106,425 | 2,306 | 10,976 | 0 |
| 30 Sep 18 | 114,709 | 3,694 | 10,677 | 0 |
| 30 Jun 18 | 123,010 | 5,509 | 10,378 | 0 |
| 31 Mar 18 | 127,801 | 5,745 | 10,406 | 0 |
| 31 Dec 17 | 132,592 | 5,980 | 10,433 | 0 |
| 30 Sep 17 | 131,861 | 5,831 | 10,444 | 0 |
| 30 Jun 17 | 131,129 | 5,682 | 10,455 | 0 |
| 31 Mar 17 | 129,080 | 5,842 | 10,377 | 0 |
| 31 Dec 16 | 127,031 | 6,001 | 10,299 | 0 |
| 30 Sep 16 | 120,908 | 5,912 | 10,027 | 0 |
| 30 Jun 16 | 114,784 | 5,823 | 9,754 | 0 |
| 31 Mar 16 | 115,121 | 5,536 | 9,898 | 0 |
| 31 Dec 15 | 115,458 | 5,248 | 10,042 | 0 |
| 30 Sep 15 | 119,656 | 5,001 | 9,985 | 0 |
| 30 Jun 15 | 123,853 | 4,753 | 9,928 | 0 |
Des revenus de qualité: CS a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de CS sont inférieures à celles de l'année dernière CS. (7.7%) sont inférieures à celles de l'année dernière (7.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de CS ont augmenté de 8% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de CS au cours de l'année écoulée ( 2% ) est inférieure à sa moyenne sur 5 ans ( 8% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices CS au cours de l'année écoulée ( 2% ) n'a pas surpassé celle du secteur Insurance 19.3%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de CS ( 14.4% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/08 04:37 |
| Cours de l'action en fin de journée | 2026/06/08 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
AXA SA est couverte par 34 analystes. 12 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Markus Mayer | Baader Helvea Equity Research |
| null null | Banco de Sabadell. S.A. |
| Valvanera Gómez Pastor | Banco Santander |